Theme: New Therapies to Improve Liver Transplant Outcomes

Liver Transplant 2020

Liver Transplant 2020

We are glad to announce the “International Congress on Gastroenterology and Liver Transplant,” which is scheduled during December 07-08, 2020 Auckland, Newzeland in collaboration with generous support and cooperation from enthusiastic academicians and Organizing Committee Members. The conference will highlight the “New Therapies to Improve Liver Transplant Outcomes."

The goals of the conference are to provide a transformative professional development experience and bringing together the world’s scientific experts to catalyze and advance scientific knowledge about Liver Diseases and Gastroenterology and to accelerate the development and application of new technologies to produce dynamic pictures and its related study designs. Emphasizes Evidence-based Practice, Educational Innovation, Practical Application, and Peer to Peer Networking and Collaboration. This is the best chance to achieve the biggest collection of members from the Gastroenterology people group. Direct introductions, appropriate data, meet with present and potential researchers, make a sprinkle with better approaches for treatment and mind and get name acknowledgment at this 2-day conference. Widely acclaimed speakers, the latest systems, advancements, and the most up to date refreshes in Gastroenterology are signs of this meeting.

Liver Transplant 2020 will congregate renowned speakers, principal investigators, experts and researchers from both academia and healthcare industry will join to discuss their views and research. We cordially invite all the participants who are interested in sharing their knowledge and research in these studies.

Track 01: Liver Diseases

Liver disease is any disturbance of liver function that causes illness. The liver is responsible for many critical functions within the body and should it become diseased or injured, the loss of those functions can cause significant damage to the body. Liver disease is also referred to as hepatic disease. Liver disease is a broad term that covers all the potential problems that cause the liver to fail to perform its designated functions. Usually, more than 75% or three quarters of liver tissue needs to be affected before a decrease in function occurs.

Types of Liver Diseases including:-

Metabolic diseases
Autoimmune liver diseases
Vascular disorders
Genetic Liver Disease
Wilson disease
Non-alcoholic fatty liver disease

Related Conference:

19th International Conference on Gastroenterology and Hepatology | November 18-19, 2019 Abu Dhabi, UAE | 10th International Conference on Liver Diseases & Hepatology, December 02-03, 2019, Tokyo, Japan | 15thAnnual Congress on Gastroenterology & Hepatology, March 30-31, 2020 Hong Kong |18th International Conference on Gastroenterology and Digestive Disorders | November 18-19, 2019 Dubai, UAE | 16th World Congress on Gastroenterology & Therapeutics, April 06-07, 2020 Osaka, Japan

Related Associations:

Asia Pacific

Asia-Pacific and Middle East: Taiwan Liver Cancer Association (TLCA) |Liver Conferences | Asian Pacific Association of Gastroenterology (APAGE) | Liver Transplant Conferences | Asian Pacific Society of Digestive Endoscopy (APSDE) | Gastroenterology conferences| Asian Pacific Association for the Study of the Liver (APASL) | Liver Transplant 2020 | Bowel Cancer Australia (BCA) | Gastroenterological Society of Australia (GESA) | Gastroenterology Conferences | Australian and New Zealand Gastric and Oesophageal Surgery Association |Philippine Society of Gastroenterology (PSG) British Society of Gastroenterology |Liver conferences 2020| European Association for Gastroenterology, Endoscopy & Nutrition | Hepatology conferences | Auckland Gastroenterology Associates | Gastroenterological Scientific Society of Russia

Europe

USA

American College of Gastroenterology |Hepatology conferences | American Gastroenterological Association (AGA) | Hepatology Conferences 2020 North American Society for Paediatric Gastroenterology | Hepatology and Nutrition (NASPGHAN) | NEW YORK Society For Gastrointestinal Endoscopy( NYSGE) | Gastroenterology conferences 2020 South Florida Gastroenterology Associates, P.A | Liver Conference 2020| Ohio Gastroenterology Society (OGS) | American Gastroenterological Association (AGA) | Hepatology conferences North American Society for Paediatric Gastroenterology | Hepatology and Nutrition (NASPGHAN) | Hepatology 2020 NEW YORK Society For Gastrointestinal Endoscopy( NYSGE)

Track 02: Viral hepatitis

Viral hepatitis is an infection that causes liver inflammation and damage. Inflammation is swelling that occurs when tissues of the body become injured or infected. Inflammation can damage organs. Researchers have discovered several different viruses that cause hepatitis, including:-

hepatitis A
hepatitis B
hepatitis C
hepatitis D
hepatitis E

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 03: Cirrhosis of the liver (Alcoholic Liver Disease)

Cirrhosis is a slowly developing disease in which healthy liver tissue is replaced with scar tissue. The scar tissue blocks the flow of blood through the liver and slows the liver’s ability to process nutrients, hormones, drugs and natural toxins (poisons). It also reduces the production of proteins and other substances made by the liver. Cirrhosis eventually keeps the liver from working properly.

Fatty liver
Alcoholic hepatitis
Chronic hepatitis

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 04: Hepatic Cysts

Liver cysts are fluid-filled sacs that form in the liver. They’re benign growths, meaning they aren’t cancerous. These cysts generally don’t require treatment unless symptoms develop, and they rarely affect liver function. Liver cysts are the result of a malformation in the bile ducts, although the exact cause of this malformation is unknown. Bile is a fluid made by the liver, which aids in digestion. This fluid travels from the liver to the gallbladder through ducts or tube-like structures.

Simple cysts
Multiple cysts arising in the setting of polycystic liver disease (PCLD)
Parasitic or hydatid (echinococcal) cysts
Cystic tumors
Abscesses

Ductal cysts, choledochal cysts, and Caroli disease are differentiated from hepatic cysts by involvement of the bile ducts and are not reviewed in this article.

Related Conferences:

Related Associations

Asia Pacific

Europe

USA

Track 05: Liver Cancer

Liver cancer is cancer that begins in the cells of the liver. The liver is a football-sized organ that sits in the upper right portion of your abdomen, beneath your diaphragm and above your stomach. Cancer that spreads to the liver is more common than cancer that begins in the liver cells. Cancer that begins in another area of the body — such as the colon, lung or breast — and then spreads to the liver is called metastatic cancer rather than liver cancer. This type of cancer is named after the organ in which it began — such as metastatic colon cancer to describe cancer that begins in the colon and spreads to the liver.

Several types of cancer can form in the liver. The most common type of liver cancer is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte).

Hepatocellular Carcinoma
Intrahepatic Cholangiocarcinoma
Hepatoblastoma

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 06: Liver Transplantation

A liver transplant is surgery to replace a diseased liver with a healthy liver from another person. A whole liver may be transplanted, or just part of one. In most cases the healthy liver will come from an organ donor who has just died. Sometimes a healthy living person will donate part of their liver. A living donor may be a family member. Or it may be someone who is not related to you but whose blood type is a good match. People who donate part of their liver can have healthy lives with the liver that is left.

The liver is the only organ in the body that can replace lost or injured tissue (regenerate). The donor’s liver will soon grow back to normal size after surgery. The part that you receive as a new liver will also grow to normal size in a few weeks.

Types of Liver Transplantation

Orthotopic transplant
Living donor transplant
Split type of liver transplant
Split type of liver transplant

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 07: Pancreatic Cancer

Pancreatic cancer is a disease in which malignant (cancerous) cells form in the tissues of the pancreas. The pancreas is a gland located behind the stomach and in front of the spine. The pancreas produces digestive juices and hormones that regulate blood sugar. Cells called exocrine pancreas cells produce the digestive juices, while cells called endocrine pancreas cells produce the hormones. The majority of pancreatic cancers start in the exocrine cells.

Exocrine tumors
Neuroendocrine tumors

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 10: Gallbladder Diseases

The gallbladder is a small pouch that sits just under the liver. The gallbladder stores bile produced by the liver. After meals, the gallbladder is empty and flat, like a deflated balloon. Before a meal, the gallbladder may be full of bile and about the size of a small pear. In response to signals, the gallbladder squeezes stored bile into the small intestine through a series of tubes called ducts. Bile helps digest fats, but the gallbladder itself is not essential. Removing the gallbladder in an otherwise healthy individual typically causes no observable problems with health or digestion yet there may be a small risk of diarrhea and fat malabsorption.

Gallbladder diseases considered here include

Gallstones,
Tumors,
Acute acalculous cholecystitis.

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 11: Disorders of hepatobiliary system

Disorders of the liver and biliary system (which creates and stores bile) may require surgical correction. These disorders can be developmental or congenital, or they may manifest later in childhood or adolescence.

Benign gallbladder diseases include infections (cholecystitis) and gallstones causing symptoms (biliary colic).
Bile duct cysts (choledochal cysts) stem from abnormal development of the biliary system and have been associated with cancer (cholangiocarcinoma) as well as infection of the bile duct (cholangitis).
Biliary atresia can prevent bile from being able to drain from the liver into the intestine. It stems from abnormal development of the biliary system.

Related Associations:

Asia Pacific

Europe

USA

Track 12: Hemochromatosis

Hemochromatosis is a disorder where too much iron builds up in the body. Sometimes it’s called “iron overload.” Normally, our intestines absorb just the right amount of iron from the foods we eat. But in hemochromatosis, our body absorbs too much, and it has no way to get rid of it. So, our body stores the excess iron in our joints and in organs like our liver, heart, and pancreas. This damages them. If it’s not treated, hemochromatosis can make our organs stop working.

There are two types of this condition primary and secondary.

Primary hemochromatosis
Secondary hemochromatosis

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 13: Pediatric and Geriatric Hepatology

Liver diseases are mostly seen as in a grown-up, however, a huge number of children from babies to teens experience from different types of liver diseases. The volume of the liver and the blood flow decreases with age, immune responses against pathogens or neoplastic cells are lower in the elderly reducing their tolerability to treatments for liver diseases. Liver regeneration capacity shows a decline in age, reduced proliferation of hepatocytes, but the level of hepatic enzymes and high-density lipoprotein cholesterol is well maintained. Pediatric Hepatology focuses on the diagnosis and treatment of liver and liver-related disease in infants and children.

Related conferences:

Related Associations:

Asia Pacific

Europe

USA

Track 14: Causes of Hepatitis

Inflammation of the liver characterized by diffuse or patchy necrosis is Hepatitis . Auto immune hepatitis (AIH) is one exception. When your immune system attacks your liver cells this type of liver disease occurs. AIH is chronic condition that can result in cirrhosis (scarring) of the liver.. Auto immune hepatitis likely results from a combination of auto immunity, environmental triggers, and a genetic predisposition. It occurs more frequently in females. Treatment includes corticosteroids and medications that suppress the immune system. Liver transplant may be needed In severe cases). Liver is not inflamed in ischemic hepatitis. Rather, liver cell death occurs. The term hepatitis is used because technically, it refers to any disorder in which liver enzymes called amino transfer case leak from damaged liver cells into the blood.

Auto immune hepatitis

Infectious

Ischemic hepatitis

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 15: Clinical Gastroenterology

The journal present up-to-date coverage of basic and clinical researches on molecular and cell biology, pathophysiology, epidermal, diagnosis, and treatment of the various diseases of the liver and biliary tract, B viral hepatitis and hepatocellular carcinoma are the common liver diseases in Asian-pacific region. Idiosyncratic drug induced liver injury (Dili) is a rare adverse druid reaction and it can lead to jaundice, liver failure, or even death. In the Western world Antimicrobials and herbal and dietary supplements are among the most common therapeutic classes to cause DILI. Liver fibrosis is the excessive accumulation of extra cellular proteins collagen that occurs in most types of chronic liver diseases.

Drug induced liver injury

Liver Fibrosis

Jaundice

Related Conference:

Related Associations:

Asia Pacific

Europe

USA

Track 16: Clinical research in Gastroenterology

Clinical Gastroenterology is a series of concise monographs on diseases commonly encountered in the clinical practice of Internal Medicine and Gastroenterology. Particular emphasis is placed on areas in which knowledge is advancing rapidly. Clinical Gastroenterology includes practical information of companies or laboratories that perform specialized testing, relative costs of diagnostic and therapeutic options.

The series is of great value to Gastroenterologists and Hepatologists interested in the latest practical developments in the field as well as Internists who have particular interests or large numbers of patients with particular diseases in the field of Gastroenterology-Hepatology.

Related Conference:

10th International Conference on Liver Diseases & Hepatology, December 02-03, 2019, Tokyo, Japan | 15thAnnual Congress on Gastroenterology & Hepatology, March 30-31, 2020 Hong Kong |18th International Conference on Gastroenterology and Digestive Disorders | November 18-19, 2019 Dubai, UAE | 16th World Congress on Gastroenterology & Therapeutics, April 06-07, 2020 Osaka, Japan

Related Associations:

Asia Pacific

Europe

USA

Track 17: Pancreatic disease

The pancreas is a large gland behind the stomach and next to the small intestine which produces juices that help break down food and hormones and help control blood sugar levels. The pancreas does two main things:

It releases powerful digestive enzymes into the small intestine to aid the digestion of food.

It releases the hormones insulin and glucagon into the bloodstream. These hormones help the body control how it uses food for energy.

Pancreatitis is a disease in which the pancreas converts inflamed. Pancreatic destruction happens when the digestive enzymes are triggered before they are released into the small intestine and initiate attacking the pancreas.

There are binary forms of pancreatitis: (1) Acute and (2) Chronic.

Related Conference:

Related Associations:

Asia Pacific

Asia Pacific

Europe

USA

Market Scenario

Gastrointestinal Diseases Market valued USD 17.59 Billion in 2017 and expected to reach USD 21.67 Billion by 2026, at a CAGR of 2.64%.

The market for Gastrointestinal Diseases is primarily depended on increasing life expectancy and improved accessibility to healthcare facilities worldwide. Various factors to be considered for Gastrointestinal Diseases include continuous consideration by analysis of patient’s oxygenation, ventilation, blood circulation, and body temperature.

Report includes assessment of Global Gastrointestinal Diseases Market definition along with the identification of key players and analysis of their strategies, complete quantitative analysis of the industry from 2017 to 2026 to enable the stakeholders to capitalize on the prevailing market opportunities, market analysis and comprehensive segmentation with respect to the drug category and geography to assist in strategic business planning.

APAC is expected to register the highest growth rate in Gastrointestinal Diseases Market during forecast period. APAC is expected to lead the Global Gastrointestinal Diseases Market during the forecast period. Growing investments and funding in the field of life science research and advanced therapies for the treatment of gastrointestinal diseases in developing nations such as China and India will fuel the Global Gastrointestinal Diseases Market in APAC region.

Scope of the Report:

Global Gastrointestinal Diseases Market, By Drug Category:

• Antacid & Anti-Ulcerant

• GIT Anti-inflammatory

• Antiemetic, Anti-diarrhea

• Other GIT Therapeutics

Global Gastrointestinal Diseases Market, By Geography:

• North America

• Europe

• Asia Pacific

• Middle East and Africa

• Latin America

Key players in Global Gastrointestinal Diseases Market are:

• AstraZeneca

• Shire

• Valeant (Salix Pharmaceuticals)

• Takeda Pharmaceutical Company Limited

• Eisai Co. Ltd.

• Allergan

• Johnson & Johnson Private Limited

Available Customization

Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client

Reference : https://www.maximizemarketresearch.com/market-report/gastrointestinal-diseases-market/304/

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	December 07-08, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

International Congress on Gastroenterology and Liver Transplant December 07-08, 2020 Auckland, Newzealand

Recommended Global Gastroenterology Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Liver Transplant 2020

Market Scenario

Gastrointestinal Diseases Market valued USD 17.59 Billion in 2017 and expected to reach USD 21.67 Billion by 2026, at a CAGR of 2.64%.

Scope of the Report:

Global Gastrointestinal Diseases Market, By Drug Category:

• Antacid & Anti-Ulcerant

• GIT Anti-inflammatory

• Antiemetic, Anti-diarrhea

• Other GIT Therapeutics

Global Gastrointestinal Diseases Market, By Geography:

• North America

• Europe

• Asia Pacific

• Middle East and Africa

• Latin America

Key players in Global Gastrointestinal Diseases Market are:

• AstraZeneca

• Shire

• Valeant (Salix Pharmaceuticals)

• Takeda Pharmaceutical Company Limited

• Eisai Co. Ltd.

• Allergan

• Johnson & Johnson Private Limited

Available Customization

Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client

Reference : https://www.maximizemarketresearch.com/market-report/gastrointestinal-diseases-market/304/

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Liver Transplant 2020

Market Scenario

Gastrointestinal Diseases Market valued USD 17.59 Billion in 2017 and expected to reach USD 21.67 Billion by 2026, at a CAGR of 2.64%.

Scope of the Report:

Global Gastrointestinal Diseases Market, By Drug Category:

• Antacid & Anti-Ulcerant

• GIT Anti-inflammatory

• Antiemetic, Anti-diarrhea

• Other GIT Therapeutics

Global Gastrointestinal Diseases Market, By Geography:

• North America

• Europe

• Asia Pacific

• Middle East and Africa

• Latin America Key players in Global Gastrointestinal Diseases Market are:

• AstraZeneca

• Shire

• Valeant (Salix Pharmaceuticals)

• Takeda Pharmaceutical Company Limited

• Eisai Co. Ltd.

• Allergan

• Johnson & Johnson Private Limited

Available Customization

Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client

Reference : https://www.maximizemarketresearch.com/market-report/gastrointestinal-diseases-market/304/

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues

• Latin America

Key players in Global Gastrointestinal Diseases Market are: